- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03568903
Changes in Functional Performance in Individuals With Parkinson's Disease Following 2-month Physiotherapy Intervention
Functional Performance in Individuals With Parkinson's Disease: Changes Following 2-month Physiotherapy Intervention in Small Groups and Impact of Disease Progression
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of current study was to enroll 50 patients with Parkinson's disease (PD) and randomly assign them into intervention and control group. Patients were randomly contacted through the epidemiological database of patients with Parkinson' disease of South-Estonia. 44 participants agreed to come to the baseline assessment including:
- Timed-Up-And-Go Test Battery
- Four square step test
- Physical performance test
- Short Physical Performance
- 10-m walk test
- Grooved Purdue Pegboard test
- Assessment of range of motion In addition, current disease status was assessed using Unified Parkinson Disease Rating Scale, Mini Mental Sate Examination. Further, quality of life was assessed using PDQ-39, hand-writing was recorded using white, squared and striped paper and freezing of gait questionaire (FOG-Q) was administered. Within a week from baseline assessment participants randomly assigned to intervention group, started physiotherapy intervention. The intervention was carried out in small groups (3 people in a group) and was carried out as out-patient physiotherapy during 8 week period. During each week 2 sessions with a length of an hour were scheduled. Within a week of the last therapy session, second assessment was conducted (for control group the second assessment was carried out ten weeks post-baseline assessment.
Third assessment was assigned one year after (then the same assessment was performed, in addition body composition was analysed using DXA), forth assessment an other year later.
During forth assessment 15 members starting in the intervention group and 10 starting in the control group participated.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- confirmed diagnosis of idiopathic Parkinson Disease
- age within the age limits
- no other untreated medical conditions that might affect gait or postural stability
- able to walk without assistive device
- score of Mini Mental State Examination above 24
- no other neurological conditions in medical anamnesis
Exclusion Criteria:
Not meeting the inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Comprehensive physical therapy intervention in small groups (3 members), altogether 16 sessions were performed during a period of 8 weeks (twice a week).
Each session lasted 1 hour.
|
Each session included exercises for posture, strength, range of motion, balance.
In addition, different transfers and gait training was performed.
Each session began with exercises in laying position (15 minutes), thereafter exercises in sitting were performed for 10 minutes.
Then different exercises in standing position were performed for 15 minutes, followed by 10 minutes of gait training.
10 minutes of exercises for manual dexterity and upper limb function ended the session.
|
No Intervention: Control group
Control group members did not receive any specific intervention during study period, but if needed, medical treatment (medication, it's dosage etc) of Parkinson Disease was changed during study period.
They were assigned to individual therapy after the study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gait speed during transitioning from sitting to walking and its change as a result of physiotherapy and change over time
Time Frame: it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
Gait speed was calculated based an the performance of Timed up and Go test
|
it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
Gait speed during transitioning from standing to walking and its change as a result of physiotherapy and change over time
Time Frame: it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
Gait speed was calculated based an the performance of Short Physical Performance Battery gait test
|
it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
"Pure" gait speed and its change as a result of physiotherapy and change over time
Time Frame: it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
Gait speed was calculated based an the performance of 10 m walk test, with excluding the acceleration and deceleration phase (duration of the intermediate 6-meters was measured and based on that gait speed was calculated
|
it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
body composition (and changes in it in one year period)
Time Frame: was assessed twice (during third and fourth assessment), with a timeperiod of one year in between
|
it was assessed with DXA methodology
|
was assessed twice (during third and fourth assessment), with a timeperiod of one year in between
|
Timed-up-and-go test: its change as a result of physiotherapy and change over time
Time Frame: it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
The duration of Timed up and go test, executed with a turn over both shoulders was used
|
it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
Four square step test: its change as a result of physiotherapy and change over time
Time Frame: it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
The duration of Four square step test,was used
|
it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
Tinetti test: its change as a result of physiotherapy and change over time
Time Frame: it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
The Tinetti test was executed and the score was used
|
it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
Range of motion: its change as a result of physiotherapy and change over time
Time Frame: it was assessed during three assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later
|
Range of motion of major joints (shoulder, hip, knee, ankle) were measured goniometrically.
Spinal ROM (including neck) was measured with tapemeasure, aswell as the excursion of the ribcage during maximal inspiration and expiration
|
it was assessed during three assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later
|
Assessment of handwriting:its change as a result of physiotherapy and change over time
Time Frame: it was assessed during three assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later
|
To assess the impact of visual cues on handwriting, patients were instructed to write one simple and one complex sentence on white, striped and squared paper.
During assessment, the speed of writing was registered.
|
it was assessed during three assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life: its change as a result of physiotherapy and change over time
Time Frame: it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
it was assessed with PDQ-39 questionaire
|
it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
prevalence of pain: its change as a result of physiotherapy and change over time
Time Frame: it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
it was assessed with patient interview
|
it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
patient-specific complaints:its change as a result of physiotherapy and change over time
Time Frame: it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
it was assessed with patient interview
|
it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
difficulties in executing different activities of daily living: its change as a result of physiotherapy and change over time
Time Frame: it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
it was assessed with patient interview
|
it was assessed during all the assessments: at baseline, during second assessment ten weeks later, third assessment was carried out one year later, forth assessment was conducted another year later
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kadri Medijainen, MSc, Junior research fellow in physiotherapy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PD_Comprehensive_PT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Comprehensive physical therapy
-
Sherin Hassan Mohammed MehaniCompletedMechanical Ventilation ComplicationEgypt
-
Shanghai Ninth People's Hospital Affiliated to...Shanghai Jiao Tong University School of MedicineRecruiting
-
Odense University HospitalZealand University Hospital; Rigshospitalet, Denmark; Herlev HospitalRecruitingOvarian Cancer | FrailtyDenmark
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMultiple Myeloma | B-Cell Non-Hodgkin LymphomaUnited States
-
Rigshospitalet, DenmarkCopenhagen University Hospital - Rigshospitalet, Department of Occupational... and other collaboratorsRecruitingCancer | Colorectal Cancer | Chemotherapy | Exercise | Sarcopenia | Vertigo | Rehabilitation | Elderly | Older Adults | Resistance Training | Geriatric | Chemotherapy-induced Peripheral Neuropathy | Vestibular Rehabilitation | Oncologic Complications | Comprehensive Geriatric Assessment | Frail | Postural Stability | Balance... and other conditionsDenmark
-
Fondazione Salvatore MaugeriUnknownParkinson's Disease
-
Wroclaw Medical UniversityFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; University of Valencia and other collaboratorsUnknown
-
Riphah International UniversityCompleted
-
Mayo ClinicDePuy OrthopaedicsCompleted